2-(5-bromo-2-chloropyrimidin-4-yl)oxy-N-cyclopropylbenzamide;2-[5-bromo-2-(3,4-dimethoxy-5-methylanilino)pyrimidin-4-yl]oxy-N-cyclopropylbenzamide;dichlorozinc;N,N-diethylethanamine;3,4-dimethoxy-5-methylaniline
C52H62Br2Cl3N9O8Zn — CID 161162543
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(5-bromo-2-chloropyrimidin-4-yl)oxy-N-cyclopropylbenzamide;2-[5-bromo-2-(3,4-dimethoxy-5-methylanilino)pyrimidin-4-yl]oxy-N-cyclopropylbenzamide;dichlorozinc;N,N-diethylethanamine;3,4-dimethoxy-5-methylaniline
2-(5-bromo-2-chloropyrimidin-4-yl)oxy-N-cyclopropylbenzamide;2-[5-bromo-2-(3,4-dimethoxy-5-methylanilino)pyrimidin-4-yl]oxy-N-cyclopropylbenzamide;dichlorozinc;N,N-diethylethanamine;3,4-dimethoxy-5-methylaniline (PubChem CID 161162543) has the molecular formula C52H62Br2Cl3N9O8Zn and a molecular weight of 1272.68 g/mol. Its IUPAC name is 2-(5-bromo-2-chloropyrimidin-4-yl)oxy-N-cyclopropylbenzamide;2-[5-bromo-2-(3,4-dimethoxy-5-methylanilino)pyrimidin-4-yl]oxy-N-cyclopropylbenzamide;dichlorozinc;N,N-diethylethanamine;3,4-dimethoxy-5-methylaniline.
Molecular Properties
| Compound Name | 2-(5-bromo-2-chloropyrimidin-4-yl)oxy-N-cyclopropylbenzamide;2-[5-bromo-2-(3,4-dimethoxy-5-methylanilino)pyrimidin-4-yl]oxy-N-cyclopropylbenzamide;dichlorozinc;N,N-diethylethanamine;3,4-dimethoxy-5-methylaniline |
|---|---|
| PubChem CID | 161162543 |
| Molecular Formula | C52H62Br2Cl3N9O8Zn |
| Molecular Weight | 1272.68 g/mol |
| Exact Mass | 1267.14 |
| IUPAC Name | 2-(5-bromo-2-chloropyrimidin-4-yl)oxy-N-cyclopropylbenzamide;2-[5-bromo-2-(3,4-dimethoxy-5-methylanilino)pyrimidin-4-yl]oxy-N-cyclopropylbenzamide;dichlorozinc;N,N-diethylethanamine;3,4-dimethoxy-5-methylaniline |
| SMILES | CCN(CC)CC.COc1cc(N)cc(C)c1OC.COc1cc(Nc2ncc(Br)c(Oc3ccccc3C(=O)NC3CC3)n2)cc(C)c1OC.Cl[Zn]Cl.O=C(NC1CC1)c1ccccc1Oc1nc(Cl)ncc1Br |
| InChI | InChI=1S/C23H23BrN4O4.C14H11BrClN3O2.C9H13NO2.C6H15N.2ClH.Zn/c1-13-10-15(11-19(30-2)20(13)31-3)27-23-25-12-17(24)22(28-23)32-18-7-5-4-6-16(18)21(29)26-14-8-9-14;15-10-7-17-14(16)19-13(10)21-11-4-2-1-3-9(11)12(20)18-8-5-6-8;1-6-4-7(10)5-8(11-2)9(6)12-3;1-4-7(5-2)6-3;;;/h4-7,10-12,14H,8-9H2,1-3H3,(H,26,29)(H,25,27,28);1-4,7-8H,5-6H2,(H,18,20);4-5H,10H2,1-3H3;4-6H2,1-3H3;2*1H;/q;;;;;;+2/p-2 |
| InChIKey | UQCMYYJQNFOASS-UHFFFAOYSA-L |
| XLogP | 12.89 |
| TPSA | 206.43 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1272.68 |
| LogP ≤ 5 | 12.89 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161162543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.